Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela M Lam

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Bioorganic & Medicinal Chemistry Letters|November 6, 2010
2'-deoxy-2'-α-fluoro-2'-β-C-methyl 3',5'-cyclic phosphate nucleotide prodrug analogs as inhibitors of HCV NS5B polymerase: discovery of PSI-352938P Ganapati Reddy, Donghui Bao, Wonsuk Chang, et al.
Journal of Virology|June 30, 2021
Host Poly(A) Polymerases PAPD5 and PAPD7 Provide Two Layers of Protection That Ensure the Integrity and Stability of Hepatitis B Virus RNAFei Liu, Amy C H Lee, Fang Guo, et al.
Antimicrobial Agents and Chemotherapy|June 3, 2010
PSI-7851, a pronucleotide of beta-D-2'-deoxy-2'-fluoro-2'-C-methyluridine monophosphate, is a potent and pan-genotype inhibitor of hepatitis C virus replicationAngela M Lam, Eisuke Murakami, Christine Espiritu, et al.
Antiviral Research|September 26, 2024
Preclinical and clinical antiviral characterization of AB-836, a potent capsid assembly modulator against hepatitis B virusAngela M Lam, Nagraj Mani, Andrzej Ardzinski, et al.
ACS Infectious Diseases|April 23, 2024
Discovery of <i>C</i>-Linked Nucleoside Analogues with Antiviral Activity against SARS-CoV-2Eugen F Mesaros, Benjamin J Dugan, Min Gao, et al.
Journal of Medicinal Chemistry|October 25, 2024
Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 M<sup>pro</sup> from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant VariantsXu Wang, Dimitar Gotchev, Kristi Yi Fan, et al.
Antiviral Research|November 22, 2024
Biological characterization of AB-343, a novel and potent SARS-CoV-2 M<sup>pro</sup> inhibitor with pan-coronavirus activityKayleigh R McGovern-Gooch, Nagraj Mani, Dimitar Gotchev, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Bioorganic & Medicinal Chemistry Letters|November 6, 2010
2'-deoxy-2'-α-fluoro-2'-β-C-methyl 3',5'-cyclic phosphate nucleotide prodrug analogs as inhibitors of HCV NS5B polymerase: discovery of PSI-352938P Ganapati Reddy, Donghui Bao, Wonsuk Chang, et al.
Journal of Virology|June 30, 2021
Host Poly(A) Polymerases PAPD5 and PAPD7 Provide Two Layers of Protection That Ensure the Integrity and Stability of Hepatitis B Virus RNAFei Liu, Amy C H Lee, Fang Guo, et al.
Antimicrobial Agents and Chemotherapy|June 3, 2010
PSI-7851, a pronucleotide of beta-D-2'-deoxy-2'-fluoro-2'-C-methyluridine monophosphate, is a potent and pan-genotype inhibitor of hepatitis C virus replicationAngela M Lam, Eisuke Murakami, Christine Espiritu, et al.
Antiviral Research|September 26, 2024
Preclinical and clinical antiviral characterization of AB-836, a potent capsid assembly modulator against hepatitis B virusAngela M Lam, Nagraj Mani, Andrzej Ardzinski, et al.
ACS Infectious Diseases|April 23, 2024
Discovery of <i>C</i>-Linked Nucleoside Analogues with Antiviral Activity against SARS-CoV-2Eugen F Mesaros, Benjamin J Dugan, Min Gao, et al.
Journal of Medicinal Chemistry|October 25, 2024
Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 M<sup>pro</sup> from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant VariantsXu Wang, Dimitar Gotchev, Kristi Yi Fan, et al.
Antiviral Research|November 22, 2024
Biological characterization of AB-343, a novel and potent SARS-CoV-2 M<sup>pro</sup> inhibitor with pan-coronavirus activityKayleigh R McGovern-Gooch, Nagraj Mani, Dimitar Gotchev, et al.
Pageof 4